Hyperacusis Research Limited, Inc. is a 501(c)(3) non-profit organization dedicated to advancing biomedical research into the underlying mechanisms of hyperacusis, with the goal of developing effective treatments and ultimately finding a cure.
We focus specifically on loudness hyperacusis and pain hyperacusis (also known as noxacusis)—conditions in which everyday sounds are perceived as intolerably loud or physically painful. We support the consensus definition of hyperacusis as “a reduced tolerance to sound(s) that are perceived as normal to the majority of the population or were perceived as normal to the person before their onset of hyperacusis” (Adams et al., 2020).
Our mission is driven by the urgent need for new, targeted therapies. While sound therapy approaches such as Tinnitus Retraining Therapy (TRT) are available, many patients do not respond well or experience meaningful relief. Therefore, Hyperacusis Research prioritizes funding high-impact, cross-disciplinary research aimed at discovering the biological basis of hyperacusis and translating that knowledge into innovative medical treatments.
Through our grant program, we foster cross-discipline collaboration and knowledge sharing among scientists and institutions committed to solving this debilitating condition. We do not conduct research into misophonia, phonophobia, or other sound tolerance disorders outside the scope of loudness and pain hyperacusis.
Our goal is to improve the quality of life for those affected by hyperacusis by supporting the scientific breakthroughs that will lead to lasting relief.
Roadmap to a Cure
Hyperacusis Research worked with 18 researchers from around the world to create the first comprehensive Roadmap to a Cure for Hyperacusis. For more details on the roadmap below check out our summary report.
